H. J. Haisma obtained his Ph.D. degree from the University of Utrecht, Utrecht, The Netherlands with the thesis “Monoclonal antibodies and cancer.” He worked as Scientist for the biotech company Centocor Inc., Malvern, PA, USA (1985-1986), Dana-Farber Cancer Institute, Brigham and Women’s Hospital Boston MA, USA (1986-1987), and as instructor at Harvard Medical School, Boston, MA, USA (1986-1987). From 1987 to 1997, he worked as Scientist in the Division of Experimental Therapy, Department of Medical Oncology, Free University Hospital of Amsterdam, Amsterdam, The Netherlands. In 1997, he was appointed Assistant Professor/Section leader of the Division of Gene Therapy within this department. In 2000, he left Amsterdam to become Full Professor and Chairman of the division of Pharmaceutical Gene Modulation, Department of Pharmacy, University of Groningen, Groningen, The Netherlands. His research is devoted to the development of genetic medicines for therapeutic intervention of gene expression in patients. He is a member of the editorial board of several journals and has coauthored over 100 publications and holds several patents. He is a board member of the Dutch Society of Gene Therapy, the Dutch Society for Pharmaceutical Sciences, and the European Society for Cell and Gene Therapy.
Biography Updated on 26 February 2015